Cargando…
Tyrosine Kinase Targeting: A Potential Therapeutic Strategy for Diabetes
Tyrosine kinase inhibitors (TKIs) have been studied extensively in cancer research, ultimately resulting in the approval of many drugs for cancer therapy. Recent evidence from reported clinical cases and experimental studies have suggested that some of these drugs have a potential role in diabetes t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555044/ https://www.ncbi.nlm.nih.gov/pubmed/36247049 http://dx.doi.org/10.4103/sjmms.sjmms_492_21 |